Literature DB >> 6767790

Experimental osteomyelitis caused by Pseudomonas aeruginosa.

C W Norden, E Keleti.   

Abstract

An experimental model of chronic osteomyelitis caused by Pseudomonas aeruginosa was established with use of techniques identical to those employed previously with Staphylococcus. Infection of bone was consistently produced, but the disease was less severe than that seen with Staphylococcus. There were lower mortality, decreased severity of infection as demonstrated by X ray, and less evidence of sequestrum formation with P. aeruginosa than with Staphylococcus. Carbenicillin was used alone and in combination with sisomicin in the treatment of experimental pseudomonas osteomyelitis. The combination, when administered for four weeks, was significantly more effective than either agent alone.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767790     DOI: 10.1093/infdis/141.1.71

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

Review 1.  In vivo antibiotic synergism: contribution of animal models.

Authors:  B Fantin; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

Review 2.  Infected animal models for tissue engineering.

Authors:  Alexander M Tatara; Sarita R Shah; Carissa E Livingston; Antonios G Mikos
Journal:  Methods       Date:  2015-04-02       Impact factor: 3.608

3.  An antibiotic resistant experimental model of Pseudomonas osteomyelitis.

Authors:  D R Nelson; T B Buxton; Q N Luu; J P Rissing
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

4.  A novel canine model of acute pyogenic spondylodiscitis.

Authors:  Wei-Hua Chen; Lei-Sheng Jiang; Li-Yang Dai
Journal:  Neurosurg Rev       Date:  2009-07-15       Impact factor: 3.042

5.  Experimental osteomyelitis due to Staphylococcus aureus or Pseudomonas aeruginosa: a radiographic-pathological correlative analysis.

Authors:  C W Norden; R L Myerowitz; E Keleti
Journal:  Br J Exp Pathol       Date:  1980-08

6.  Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination.

Authors:  C W Norden; E Keleti
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

7.  Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa.

Authors:  C W Norden; M A Shaffer
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

8.  Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with teicoplanin.

Authors:  C W Norden; K Niederreiter; E M Shinners
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

Review 9.  Animal Models for Postoperative Implant-Related Spinal Infection.

Authors:  Yongjie Wang; Mingxue Che; Zhi Zheng; Jun Liu; Xue Ji; Yang Sun; Jingguo Xin; Weiquan Gong; Shibo Na; Yuanzhe Jin; Shuo Wang; Shaokun Zhang
Journal:  Orthop Surg       Date:  2022-04-25       Impact factor: 2.279

Review 10.  Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance.

Authors:  Charles W Stratton
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.